THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE ...
The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...
Warrants to be issued as part of the public offering and concurrent private placement could bring in up to $21.4 million of additional capital 30 days following the release of OPGx-BEST1 DUO-1001 ...
Opus Genetics announces $20 million public offering and $1.5 million private placement for gene therapy development and operations. Opus Genetics, Inc., a clinical-stage biotechnology company ...
the "offering") at a combined purchase price of $1.19 per share and accompanying warrant. The warrants issued pursuant to the concurrent private placement will have an exercise price of $1.19 per ...
With an estimated 34 people moving to the Charleston area each day and with South Carolina claiming one of the fastest-growing populations in ...
ROUYN-NORANDA, Quebec, April 03, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (" Abcourt ” or the " Corporation ”) (TSX ...
SEATTLE, WASHINGTON / ACCESS Newswire / April 4, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel ...
This allows for private placements, enabling access to investor ... Compared to the more stringent requirements of a registered public offering or even some other Regulation D exemptions, Rule ...
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Jo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results